schizandrin b has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, JH; Guo, C; Hou, JQ; Hu, XL; Wang, H; Xiong, F; Ye, WC; Zhang, XQ | 1 |
| Liu, W; Luo, HM; Wu, JH; Yu, R | 1 |
2 other study(ies) available for schizandrin b and Alzheimer Disease
| Article | Year |
|---|---|
Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer's Disease: Stereochemistry and Biological Activity.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Cell Line, Tumor; Cell Survival; Cyclooctanes; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Lignans; Male; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotective Agents; Polycyclic Compounds; Stereoisomerism; Treatment Outcome | 2019 |
[Gamma-Schisandrin inhibits production of amyloid beta-protein 42 in M146L cells].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclooctanes; Dose-Response Relationship, Drug; Humans; Lignans; Peptide Fragments; Polycyclic Compounds | 2006 |